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Background: Phenylketonuria (PKU) is one of the most common inborn errors 
of amino acids metabolism. WHO guidelines introduced in 1979 and revised 
1988 for breast-feeding infants with PKU included a formula containing low 
amounts of phenylalanine as a part of dietary prescription. Mental retardation 
can be prevented if PKU is diagnosed in the 1st three weeks of life and diet 
therapy started straightaway throughout life and especially in the hyper 
phenylalaninemic mothers before conception and during pregnancy.
aim of the Work: The aim of the present study was to synthesize a low-
phenylalanine formula suitable to be taken by PKU children, adolescents and 
the hyperphenylalaninemic mothers.
Materials and Method: This formula should be of high biological value, 
taken safely by those patients and to be of low cost. The formula was prepared 
from skim milk hydrolysate using two proteolytic enzymes. The first was the 
immobilized purified papain enzyme and the second was the modified protease 
XXIII prepared from Aspergillus oryzae. The skim milk hydrolysate was 
adsorbed on barium sulphate or activated carbon for removing phenylalanine. 
They were applied separately for the purpose of debittering and nutritional 
value comparison.
results: This skim milk hydrolysate had been supplemented with the amino 
acids tryptophan, tyrosine, methionine and valine. Beside the comprehensive 
amino acids analysis (Especially for the free amino acids), this formula was then 
analyzed for protein, fat, lactose and ash contents as well as microbiological and 
biological testing on mice. Hyperphenylalaninemia was induced in BALB/c 
mice model then changes in blood phenylalanine level and weight were scored 
during the periods of mutagenesis as well as the treatment period compared 
with the control group.
conclusion: The amino acids analysis showed that phenylalanine was 
0.71gm/100 gram protein in the skim milk hydrolysate compared to 3.26gm 
amino acid/100 gram protein in the skim milk. The level of free phenylalanine 
decreased from 6.34% (In the skim milk) to 0% after adsorption to barium 
sulphate and compared to 3.41% after adsorption to activated carbon. 
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introDUction                                         
Breast milk is the only food that abso-
lutely fulfills the nutritional and immu-
no-protective requirements of neonates 
and babies of all mammals. Human 
milk is consequently considered the 
best source for infants because of its 
components that play multiple roles in 
growth of infants and young babies and 
keeping them healthy.1 In some circum-
stances, however, bottle-feeding is a 
must as a substitute for mother’s milk.2 
Phenylketonuria (PKU; Mckusick 
261600) is one of such cases.
Deficiency of phenylalanine hydroxy-
lase results in failure of normal phe-
nylalanine metabolism that leads to 
accumulation of phenylalanine and its 
abnormal metabolites in the blood, all 
of the body tissues and the brain caus-
ing severe mental retardation.3 On the 
other hand, dietary noncompliance in 
pregnant women suffering hyperpheny-
lalaninemia can produce developmental 
abnormalities  and  mental impairment 
in the offspring.4 The only practical 
mode of treatment is giving the phenyl-
kutonuria patients a low-phenylalanine 
diet.5 The phenylalanine content  of 
various  protein  sources has been re-
duced by adsorption chromatography6, 
organic solvents or industrially unsuit-
able chromatographic media.7 In for-
mulae synthesis, the use of purified im-
mobilized enzymes has been reported 
to induce more stable preparation with 
higher degree of hydrolysis without mi-
crobial growth. 
This work was undertaken to establish a 
feasible protocol for removing phenyla-
lanine from skim milk using enzymatic 
hydrolysis by purified immobilized en-
zymes aiming to   achieve medically 
safe milk for such infants with PKU 
and pregnant patients with hyperpheny-
lalaninemia, with the least loss in milk 
nutritional value. A low-cost protocol 
and easy assay technique were also tar-
geted.
MaterialS anD MetHoDS             
Materials:
Dry skim milk was reconstituted by 1. 
dissolving it in demineralized water 
The formula adsorbed on barium sulphate, although it is more preserving to 
the nutritional composition; yet, it is less effective in the debittering effect 
than that adsorbed on activated carbon. This formula, in addition to being 
of high nutrional value, it is not expensive since it is obtained from skim 
milk hydrolysate. From the present study, it could be concluded that: The 
synthesized low-phenylalanine formula was effective in supplying most of 
the needed dietary intakes for conditions of hyperphenylalaninemia. The 
use of the immobilized purified Papain and modified protease XXIII from 
Aspergillus oryzae in enzymatic hydrolysis of skim milk has been proved to 
be effective in hydrolysis and emulsification.
Key Words:  
Phenylketonuria, skim milk.





(Milli-Q water prepared with Milli-
pore system and filtered on a 0.22µl 
filter Millipak) at a ratio of 1:9.
Two enzymes were used in the  en-2. 
zymatic proteolytic process; the 
1st was protease type XXIII from 
aspergillus oryzae (Cat# P-4032, 
Sigma chemical Co, USA), and the 
2nd was Papain immobilized and pu-
rified enzyme (Cat# P-4406, Sigma 
chemical Co. USA).
Adsorption materials: activated 3. 
carbon powder and barium sulphate 
powder are used for removing phe-
nylalanine from the hydrolysate.
Supplements of amino acids (Ac-4. 
cording to the FAO/WHO provision-
al pattern): Methionine (2.29mg/
gm protein), Tryptophan (0.96mg/
gm protein), Valine (4.96mg/gm 
protein) and Tyrosine 92.45mg/
gm protein) (Sigma chemicals Co. 
USA).
Supplements of vitamins and min-5. 
erals in amounts according to the 
FAO/WHO provisional pattern 
(Supplied by Sigma chemicals Co, 
USA).
Methods: 
Skim milk hydrolysates were pre-1. 
pared by two enzymes: purified 
Protease XXIII and the immobilized 
purified Papain enzyme9 in a 10% 
total solids solution. Hydrolysis 
processes were applied in a water 
bath equipped with mild  shaking 
and temperature control  capabili-
ties. Concentrations of the enzymes 
were expressed as a percentage of 
the substrate and the digestion was 
performed according to the origi-
nal method described  by Clegg 
and McMillan10 and later on by 
Lopez–Bajonero et al.11 Hydrolysis 
was stopped by heating the mixture 
for 10 minutes at 92°C then hydro-
lysate was cooled to -20°C then 
the two enzymes were applied. For 
adsorption process, the hydrolysed 
skim milk was shaken with 200% 
activated carbon vs. protein for 2 
hours at room temperature or bar-
ium sulphate 200% vs. protein for 
1 hour at 40°C. Once the separation 
process was achieved, the mixture 
was vacuum filtered. After filtering 
off the adsorbents, the hydrolysates 
were subjected to sensory analysis. 
The clear solution was concentrated 
to 25% solids by rotary evaporator. 
Both hydrolysates were stored at 
-20°C. The final product was exam-
ined for dry matter; total protein, 
non protein nitrogen, fat, ash and 
lactose (American Official Analyti-
cal Chemists).8 
Protease activity was assayed by 2. 
the method originally described by 
McDonald and Chen.12 The sub-
strate used was 1% (W/V) casein 
solution buffered at pH 7.5 using 
phosphate buffer. To 1ml casein 
solution, 1ml of the enzyme prepa-
ration was added and incubated at 
3°C for 20 minutes. Three ml of 5% 
(W/V) trichloroacetic acid was then 
added and left to stand for 30min. 
The precipitated protein was sepa-
rated by filtration. Then 1ml of fil-
trate was added to 3ml of 3.75% 
(W/V) Na2CO3 then after 10min., 
1ml of Folin reagent 1:3 dilution 
was added. The mixture was al-
lowed to stand for 30min. at 30°C 
and the absorbance was then mea-
sured at 660nm. Standard curve was 
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plotted and enzyme activity was 
expressed as U/g tyrosine released 
from casein at 30°C. Specific activ-
ity was defined as units of enzyme/
mg of protein.13 
Degree of hydrolysis was  deter-3. 
mined by precipitating the hydro-
lysate in 12% trichloroacetic acid. 
The nitrogen content of the super-
natant (NPN) was measured by mi-
cro-Kjeldahl method as follows :
D.H. (%)=NPN/total N x 10014
Adsorption process of the hydro-4. 
lysate was performed on activated 
carbon as described by Hassler15 or 
on barium sulphate as described by 
Helbig et al.16
Amino acid analysis performed on 5. 
amino acid analyzer LC3000 (Phar-
macia - Amercham, Switherland). 
HCl hydrolysis was performed pri-
or to amino acid derivatization us-
ing 6N HCl for 21 hr at 110°C. Pro-
tein determination was done where 
nitrogen content of the samples was 
determined by the micro-Kjeldahl 
method.8
Determination of fat content was 6. 
based on the original modified Ger-
ber method.17
Mineral measurements: was de-7. 
termined using atomic absorption 
spectrometry (Hitachi Ltd., Tokyo, 
Japan) according to the method of 
Morr and Foegeding.18
Moisture was determined by drying 8. 
at 105°C using air oven to have con-
stant weight according to AOAC.8
Lactose analysis according to the 9. 
original test of Dubois, et al.19
Ash was determined by incinerating 10. 
the dried samples at 550°C to con-
stant weight according to AOAC.8
Microbiological assay for safety of 11. 
the formula using total plate count20, 
detection of coliform group of mi-
croorganisms using lactose broth 
medium21 and also detection of 
yeast and molds using malt extract 
agar medium8 acidified to РH 3.5 
and incubated at 30°C for 3 days 
then the colonies were counted. 
Sensory analysis: The bitterness of 12. 
10% of aqueous treated skim milk 
hydrolysate was scored on a 9-point 
Hedonic Scale.22
Biological feeding and evaluation 13. 
on BALB/c mice (Both hyperphe-
nylalaninemic and normal control) 
as follows:
13-1. Animal feeding experiment:
Sixty-six (66) adult female BALB/c 
mice (3 weeks of age) were fed in the 
experimental animal house of the Re-
search Institute of Ophthalmology 
(Giza), under normal healthy condi-
tions for one week on a normal basal 
diet which contains salt mixture (4%), 
vitamins mixture 1%, 10% cellulose, 
65% starch, 10% corn oil and 10% 
protein.8 At the end of the adaptation 
period, mice reached an approximate 
weight of 20-25gm. The animals were 
housed in cages at room temperature 
(About 25±5°C).
13-2. Design of experiment:
After one week (Adaptation period), 
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the mice were divided into two groups, 
normal mice (18) and future mutagenic 
mice.48 The experimental diet and tap 
water were supplied adlib. Total body 
weight of the animals was recorded at 
the beginning and the end of the experi-
ment. 
13-2.1. Normal BALB/c mice (Con-
trol):
Eighteen (18) BALB/c mice (4 weeks 
of age) were divided randomly into 
three experimental groups, each con-
sists of six mice with weekly measure-
ment of blood phenylalanine and mice 
body weight; according to the follow-
ing scheme:
group 1: Fed on basal diet for 28 
days.
group 2: Fed on hydrolysate adsorbed 
on activated carbon for 28 days.
group 3: Fed on hydrolysate adsorbed 
on barium sulphate for 28 days.
13-2.2. BALB/c mice phenylketonuria 
model:
The stage of induction of mutagenesis 
lasted for 21 days. Forty-eight (48) 
normal BALB/c mice (4 weeks of age) 
were fed on 10gm of mutagenic basal 
diet containing L-ethionine (0.3% w/w) 
and L-phenylalanine (3% w/w). The 
rate of phenylalanine and ethionine 
consumption was fixed to about 1.14 
gm/week.23 Experimental animals re-
ceiving the combination of L-ethionine 
and L-phenylalanine developed hyper-
phenylalaninemia  after 2 to 3 weeks 
of dietary regimen. Every week, total 
body weight and mutagenesis material 
consumed were scored and phenylala-
nine level in blood was determined in 
blood samples withdrawn  under di-
ethyl ether  anesthesia from retrobul-
bar venous plexus of randomly chosen 
six mice according to the procedure of 
Schermer.24
13-2.3. Phenylketonuric mice under 
dietary treatment:
After three weeks period (Mutagenic 
period), eighteen18 BALB/c mice (7 
weeks of age) chosen from the muta-
genesis group and were divided ran-
domly into three experimental groups, 
each consists of six mice with weekly 
measurement of blood phenylalanine 
and mice body weight; according to the 
following scheme:-
group 1: Fed on basal diet for 28 days 
(Unrestricted diet)
group 2: Fed on hydrolysate adsorbed 
on activated carbon for 28 days.
group 3: Fed on hydrolysate adsorbed 
on barium sulphate for 28days.
13-3. Phenylalanine level:
Phenylalanine level was estimated in 
blood of mice in zero time and every 
week of the mutagenic period (21 days) 
and during the experimental feeding 
period (28 days) according to the modi-
fied procedure based on the method of 
McCaman and Robins25 using  a  HPLC 
equipment  Wallac fluorometer system 
TM (Perkin-Elmer Life Science Inc., 
Norton, OH, USA). The assay is based 
on the enhancement of the fluorescence 
of a phenylalanine-ninhydrin reaction 
product by the dipeptide, L-leucyl-L-
alanine. This method measures pheny-
lalanine quantitatively in the presence 
of other amino acids. 
reSUltS anD DiScUSSionS:                   
Table (1) shows the amino acid com-
position in skim milk and skim milk 
hydrolysate. These data revealed that 
the phenylalanine was 0.71gm% in the 
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skim milk hydrolysate compared to 
3.26% in the skim milk respectively. 
The amounts of aspartic acid, glycine 
and histidine were much higher in skim 
milk than the skim milk hydrolysate.
The other amino acids were all less de-
tectable in the skim milk. The tyrosine 
content was 3.68gm% in skim milk 
hydrolysate compared to 2.65gm% in 
skim milk.
Table (2) shows the levels of free amino 
acids in skim milk hydrolysate before 
and after adsorption. The level of phe-
nylalanine was 6.34% in the  skim  milk 
hydrolysate  before adsorption  while 
it disappeared in the formula adsorbed 
on barium sulphate and decreased to 
3.41% in the formula adsorbed on ac-
tivated carbon. The tyrosine was 1.07% 
in the barium sulphate-adsorbed formu-
la and 1.81%  in the activated carbon-
adsorbed formula compared to 5.09% 
before adsorption and 0.67% in skim 
milk. The tryptophan was 3.77% in the 
formula adsorbed on barium sulphate. 
The histidine was not detectable in the 
barium sulphate formula compared to 
1.31% in the skim milk sample. On the 
other hand, neither tryptophan nor phe-
nylalanine was detectable in the skim 
milk sample. 
Lopez Bajonero et al.11 stated that after 
phenylalanine separation on activated 
carbon, some phenylalanine remain in 
the form of low molecular weight pep-
tides rather than in the free amino acid 
form. Tyrosine and tryptophan behave 
similarly to phenylalanine. So, selec-
tion of carbon level must be adjusted. 
In general, the design criteria for car-
bon adsorption process were found to 
be 2.95gm of carbon per gm casein.
In the present study, the milk as a natu-
ral source of protein hydrolysate was 
used to obtain a low phenylalanine for-
mula.
This is in agreement with Mira et al.26 
who recommended the use of dietary 
alternatives to the synthetic amino ac-
ids mixtures free of phenylalanine and 
based on low phenylalanine protein hy-
drolysate.
In the present study, skim milk hydro-
lysate was used for synthesis of low-
phenylalanine formula and the findings 
of amino acid patterns in this study are 
in agreement with Boehm et al.27 who 
found that infants fed on whey fortifier 
had significantly higher threonine con-
centration compared to those fed ex-
clusively human milk protein whereas 
levels of some other essential amino 
acids (Valine, leucine, lysine, histidine, 
table 1: Amino acid composition* in 
skim milk and skim milk hydrolysate.





Aspartic acid 8.11 6.18
Cystine 3.45 4.54













* gm amino acid/100 gm protein.
** ND = not detectable.
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phenylalanine and tryptophan) were all 
lower in concentration. Darling et al.2 
stated that infants fed casein dominant 
formulae have higher plasma phenyla-
lanine and tyrosine concentrations than 
those fed mothers’ milk. Conversely, 
elevated plasma threonine concentra-
tions are observed in infants fed-whey 
dominant formulae. 
Benson et al.3 stated that, the goal in 
preparation of infant formula would 
be to imitate the protein or amino ac-
ids composition of human milk without 
causing metabolic stress. The amino 
acid is essential if it is demonstrated 
to promote positive nitrogen balance. 
In addition to the classic list of essen-
tial amino acids, other amino acids are 





activated carbon Barium sulphate
Alanine 1.81 2.11 3.58 7.13
Argnine 17.18 4.83 1.09 7.52
Aspartic acid ND** 8.46 9.75 7.87
Cystine ND** 5.13 2.43 ND**
Glutamic acid 13.16 18.87 16.91 14.06
Glycine 1.11 2.17 4.48 6.05
Histidine 1.31 ND** 6.64 ND**
Isoleucine 1.4 2.93 7.36 6.87
Leucine 2.43 10.48 ND** 7.8
Lysine 8.18 5.04 3.46 10.93
Methionine 1.11 3.69 2.28 2.09
Phenylalanine ND** 6.34 3.41 ND**
Prolin ND** 8.08 18.51 4.17
Serine 3.32 2.82 6.2 4.75
Threonine 6.08 2.43 4.29 5.02
Tryptophane ND** ND** ND** 3.77
Tyrosine 0.67 5.09 1.81 1.07
Valine 3.13 ND** 1.9 8.77
* gm amino acid/100 gm free amino acids.
** ND = not detectable.
table 2: Free amino acids composition* in skim milk and skim milk hydrolysate before and after 
adsorption on activated carbon and barium sulphate (%). 
necessary for the developing infants. 
Second group of amino acids known as 
semi essential, conditionally essential, 
or developmentally essential amino 
acids. Cysteine, tyrosine, histidine and 
glycine have been proposed for inclu-
sion in this list.
The nutritive value of protein mostly 
depends on its amino acids profile in 
general and the quantities of essential 
amino acids in particular. Protein re-
quirements can be satisfied by providing 
the essential amino acids rather than by 
increasing the total intake of protein.28 
Karagoz et al.29 stressed on the impor-
tance of the essential amino acids intake 
and the nature of amino acids pattern in 
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diet. The authors stated that restricted 
essential amino acids intake and al-
tered pattern of plasma amino acids 
and plasma protein levels together with 
the trace elements have adverse effects 
especially on humoral and cellular im-
mune functions. 
The aim of attaining high glutamic acid 
level for PKU patients in the skim milk 
hydrolysate formula prepared in this 
study is important in light of the find-
ing by Neu et al.30 who stated that, a 
glutamine enriched formula shows evi-
dence of improved tolerance to enteral 
feeding and situations with sepsis re-
quiring medical intervention. 
In the present study, the following ami-
no acids were added to the skim milk 
hydrolysate as a supplementation:- me-
thionine, tryptophan, valine and  ty-
rosine  (According  to  the recommend-
ed amount of FAO/WHO provisional 
pattern). 
Smith et al.31 reported a sodium inde-
pendent carrier system that  transports 
the large neutral amino acids (LNAAs) 
i.e. (Valine, isoleucine, leucine, tyrosine, 
phenylalanine, tryptophan, methionine, 
threonine and histidine) across the blood 
brain barrier. Those amino acids may 
affect behavior. In rats, an increase in 
brain tryptophan causes increase in the 
brain serotonin which had good effect 
on sleep rhythm, pain sensitivity and 
mode of aggression. Also in support for 
our results, Matalon et al.32 stated that 
large neutral amino acids lowered brain 
and blood phenylalanine levels in mice 
with PKU. This finding is explained as 
phenylalanine has the lowest Michae-
lis constant (Km), so, increasing other 
LNAAs competes with the transport of 
phenylalanine into the brain through 
shared carrier. 
Austic et al.33 stated that the branched 
chain amino acids have been reported 
to improve fetal brain development in 
PKU rats model and that large neutral 
amino acids (LNAAs) supplementas-
tion to the synthetic diet improved fetal 
amino acids profiles in maternal PKU 
conditions.
Brass et al.34 stated that the fetal  cere-
bral concentrations of methionine and 
branched chain amino acids (Valine, 
leucine and isoleucine) were decreased 
by hyperphenylalaninemia. 
The PKU diet formula should be a low 
possible protein nutrition with supple-
mentation of tyrosine.35 In PKU, with-
out restriction of dietary phenylalanine 
intake, phenylalanine  and its metabo-
lites accumulate in  blood and tissues 
and tyrosine becomes deficient. Thera-
py should consist of restricting dietary 
phenylalanine to an amount that results 
in near normal plasma phenylalanine 
concentration  and tyrosine is supple-
mented in an  effort to maintain normal 
plasma tyrosine concentration.36
Joseph and Dyer35 found that when an 
eight–fold elevated blood    phenylala-
nine decreased to near control levels, 
the blood tyrosine gradually rose to near 
normal values. However, in the brain 
frontal cortex and striatum, tyrosine 
levels increased but remained less than 
70% of the control.
Our skim milk hydrolysate preparation 
contained higher amount of isoleucine 
than FAO/WHO recommendations 
(8.22 gm% vs.4%) and more leucine 
than the FAO/WHO patterns (7.91% 
vs. 7.04% respectively) and was further 
supplemented with methionine and va-
line in light of the finding by Austic et 
al.33 that in hyperphenylalaninemic rats 
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there is lower concentrations of isoleu-
cine, leucine, valine and methionine.
Also, supplementation of the diet of 
gestating rats with mixture of LNAAs 
ameliorates the adverse effects of in-
creased phenylalanine on fetal brain 
growth and results in markedly lower 
phenylalanine concentration not only in 
fetal brain but also in fetal and maternal 
blood. The same results were obtained 
in human where dietary supplementa-
tion with LNAAs has been shown to 
lower brain phenylalanine concentra-
tion in adults with PKU.37
In PKU rats, the concentration of threo-
nine was found to be high and that of 
glycine markedly elevated in brain when 
the rats were fed increased phenylala-
nine diet, therefore, it seems desirable 
to omit threonine from the amino acids 
supplementation since threonine also is 
a precursor of glycine.33 
As shown in Table (3), skim milk has 
higher protein content (31.7gm/100gm 
dry matter) than skim milk hydrolysate 
(25.29gm/100gm dry matter) but lower 
fat, lactose and ash. The degree of hy-
drolysis was much higher for the skim 
milk hydrolysate (83.95%) than for the 
skim milk (10.15%), the non protein ni-
trogen (N.P.N) was higher in skim milk 
hydrolysate by about 7 folds, while the 
total nitrogen was higher in the skim 
milk (31.7%) than the skim milk hydro-
lysate (25.29%).






















Boza et al.38 stated that weight gain 
is associated with statistically higher 
nitrogen retention. Mahmoud et al.39 
stated that extensive hydrolysis is es-
sential to render the protein immuno-
logically unreactive. When producing 
hydrolyzed proteins, it is important to 
determine the degree of hydrolysis. Our 
results are also in agreement with Boza 
et al.40 who reported that N retention 
was higher in rats given the protein-
hydrolysate-based diets compared to 
those given the intact-protein-based di-
ets. This was  associated  with  a  lower 
urinary N excretion. It has been found 
that enzymatic hydrolysis of milk pro-
tein has equivalent effects to native pro-
tein on recovery after starvation in rats 
and even gives higher N retention with 
same gain in body weight and digest-
ibility without any noticed harmful ef-
fects.
In the present study, we used immobi-
lized purified proteolytic enzymes for 
enzymatic hydrolysis based on the find-
ing of Ge et al.41 that for the immobi-
lized papain, Km (app) was similar to 
that observed with soluble papain. Also, 
it is stable when stored at 4°C and pH 
7.5 for periods up to 8 months where-
as soluble enzymes lose their activity 
within 96 hours under similar storage 
conditions. Immobilized papain did not 
lose any activity after treatment with 
6M urea for 270 minutes whereas sol-
uble papain lost 81% of its activity due 
to altered structural and conformational 
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stability. The specificity of protease is of 
crucial importance for  both  the  degree 
of  hydrolysis  and  the  free  amino  ac-
ids  content of the hydrolysate. The im-
mobilized Aspergillus Oryzae protease 
was the most effective enzyme in break-
ing down casein molecules and releas-
ing the free amino acids from casein hy-
drolysate. It can be used for preparing 
infant formulae, and as an ingredient for 
food industry.41
Kilara and Shahani9 and Lee et al.42 and 
Tardioli et al.43 recommended inducing 
hydrolysis by immobilized enzymes.
Ambrus et al.44 reported the use of en-
zyme reactors with immobilized en-
zymes for phenylalanine depletion for 
the management of PKU. The proce-
dure was reported to be rapid and sus-
tained. Immobilized enzymes are not 
metabolized to a significant degree 
and thus small amounts can be used 
repeatedly.44,45
In our study, the degree of hydrolysis 
(DH) was (83.95%) using combined pa-
pain and protease XXIII enzymes.
This is in consistency with Lopez–
Bajonero et al.11 who induced enzy-
matic hydrolysis of skim milk powder 
by  using two enzymes, protease 2A (5 
hours) from the Aspergillus oryzae fol-
lowed by papain hydrolysis (21 hours) 
to liberate 16.5mg phenylalanine per 
gm protein. Cogan et al.46 used papain 
and pepsin; Dubois et al.19 used pronase 
and ficin; Arai et al.7 tested a series of 
enzymes with pepsin-pronase mixture; 
while Mannheim and Cheryan47 used 
continuous hydrolysis of milk protein 
in a membrane reactor using alcalase. 
Proteases being degradative enzymes 
that catalyze total hydrolysis of pro-
tein, account for about 60% of the total 
world wide sale of enzymes.48
table 4: Minerals content of skim milk, skim milk hydrolysate treated with activated carbon 
and skim Milk hydrolysate treated with barium sulphate (ppm).





























In the present study, vitamin A and Er-
gocalciferol were also added as supple-
mentation to the formula. The content 
of Zinc was highest 0.661 ppm in the 
hydrolysate treated with barium sul-
phate as compared to 0.576 pmm in the 
skim milk and only 0.375 pmm in the 
formula treated with activated carbon.
Bushueva et al.49 demonstrated the ne-
cessity of diet correction by means of 
β-carotene containing vitamin A supple-
mentation. Individuals with PKU have 
been reported to have altered trace min-
eral status.  PKU mice on unrestricted 
diet had lower hepatic zinc level and 
a greater concentration of hepatic iron 
by 1.5 times as compared to the control 
group of mice.50,51
Hyperphenylalaninemia adversely af-
fects bone status and osteocalcin in 
PKU mice.52
Fisberg et al.53 stated that PKU-for-
mulae must supply trace elements 
and vitamins that are usually supplied 
by whole protein foods. The authors 
also stated that plasma zinc of PKU 
children≥7years was significantly low-
er than normal control children.
Acosta54 found that when L-amino ac-
ids were the source of protein to PKU 
infants, their plasma retinol concentra-
tions were marginal or deficient. The 
authors attributed the cause to be the re-
stricted intake of high biological value 
protein. Karagoz         et al.29 stated that 
since all patients with PKU have zinc 
deficiency, they should be supplement-
ed with zinc regularly. 
Hogan et al.55 emphasized the impor-
tance of records of diet intakes espe-
cially for total protein and vitamins 
(D, E,A, ascorbic acid and B-complex 
group) to be adequate in PKU patients 
on phenylalanine restricted diets. 
Matalon et al.32 clarified the importance 
of medical food supplementation espe-
cially for women with PKU on  medi-
cal  food  where  protein intake is low; 
therefore, vitamin and mineral intake 
could be subsequently inadequate.
In the present study, amino acids pat-
tern was more preserved with the use 
of barium sulphate (BaSO4) but bitter-
ness depletion was achieved more by 
adsorption on activated carbon.
This is in agreement with Dubois et 
al.19 who compared various adsorption 
methods for debittering skim milk hy-
drolysates. They found that, bitter pep-
tides were mostly hydrophobic as they 
were almost completely eliminated by 
hydrophobic chromatography on hexy-
lepoxy sepharose. Activated carbon 
was the most effective in adsorbing bit-
ter peptides. The inorganic adsorbents 
barium sulphate (BaSO4) and Fuller’s 
earth exhibited negligible bitter peptide 
adsorption capacity as did the plastic 
low density polyethylene and polyvi-
nylidene chloride. However, analysis 
of activated carbon-treated skim milk 
hydrolysate revealed 60% decrease in 
riboflavin and 3% decrease in  protein 
without  any  change  in  lactose, cal-
cium and Ash content.  Essential  amino 
acids analysis  indicated that the levels 
of leucine, isoleucine, valine and total 
aromatic amino acids dropped during 
treatment to 81% of the reference val-
ues.19
Microbiological assay was done to en-
sure that sterility was maintained dur-
ing sample preparation, so; standard 
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count, coli form, mold and yeast testing 
were performed. After storage, the to-
tal bacterial count as well as yeast and 
mold counts were 13x102 per gram and 
37x101/gm respectively. On the other 
hand, coli forms were not detectable in 
any of the prepared samples. 
Marero et al.56 recommended that for 
infant formulae to be microbiologically 
safe for consumption, it should be free 
from coliforms and might have low  to-
tal plate count (TPC) at max.(102).
Brindisi et al.57 stated that sterility 
should be maintained during sample 
preparation through standard plate 
counts (SPC) and coliform tests. 
The Egyptian Organization for stan-
dardization and quality control neces-
sitates that total bacterial count should 
not be more than 1000 organisms/gm 
for infants’ food which is prepared 
without boiling. Coliform group should 
be less than 10 organisms per gram food 
which is prepared for use by boiling for 
3 minutes or less and should be free of 
E.coli. 
As shown in Table (5) the cumulative 
increase in phenylalanine level was ac-
companied by progressive decrease in 
weight of mice (25.54% in 1st week 
up to 47.55% by end of 3rd week of 
mutagenic period). The rate of weight 
loss was highest from day 0 to day 7 
(7.45gm; 25.54%) and least from day 
14 to day 21 (2gm only; 11.5%).
Because of the ethical aspects of with-
holding dietary treatment from patients 
with PKU, effectively studying long-
term effects as post natal growth rates 
is difficult or impossible. The mutant 
mice animal model for human PKU, 
provides  an  opportunity  to  conduct 
studies to clarify these issues.58
Schott et al.23 stated that valid animal 
models became available when the phe-
nylalanine hydroxylase inhibitors as p-
chlorophenylalanine and alpha-methyl 
phenylalanine were introduced. The 
female adult NMRI mice were  used as 
a PKU model with 0.3% ethionine  and 
3%  phenylalanine  as PAH inhibitors. 
BALB/c mice and some other strains of 
rats have been used as suitable animal 
models to study PKU in many other 
studies by Brass et al.34, Yannicelli 
and Medeiros52; Joseph and Dyer35 and 
Gropper et al.51
The level of blood phenylalanine in 
surviving mice increased in a     cumu-
lative manner about 3.75 folds ranging 
from 1.327mg/dl (day 0) to 4.976mg/dl 
table 5: Effect of the mutagenic diet containing 3% L-phenylalanine and 0.3% L-ethionine on mice 









































(day 21). The highest increase in level 
of phenylalanine existed between day 7 
and day 14 (2.445 folds), while the rate 
of increase in level of phenylalanine in 
1st and 3rd weeks was similar (1.2 fold 
increase). On the other hand, the high-
est value of phenylalanine among those 
died mice reached up to 10.314 mg/dl 
by the end of mutagenesis period. 
Villa Trevino et al.59 found that applying 
high dosage of ethionine together with 
phenylalanine additionally resulted in 
up to 57-fold increase in the concentra-
tion of phenylalanine.
Alpha-methylphenylalanine reduces 
the phenylalanine hydroxylase activ-
ity of rat liver by 75%. Daily injection 
and supplementation of this substance 
(Plus phenylalanine) to rats from 3rd 
to 15th day of age had no toxic effects 
and maintained a plasma concentration 
of phenylalanine comparable to that of 
phenylketonuric subjects.60
Schott  et  al.23  demonstrated  that  ap-
plying  ethionine  together with phe-
nylalanine resulted in hyperphenyla-
laninemia and PKU through inhibiting 
activity of phenylalanine hydroxylase 
and that ethionine and 3% phenyla-
lanine are useful test substances for 
studying regulation   of     phenylalanine 
hydroxylase in vivo as well as a phar-
maclogic model for phenylketonuria. 
The underlying mechanisms might be 
disturbed protein synthesis and protein 
phosphorylation through ethionine–
induced  suppression  of phenylalanine 
hydroxylase. However, a percentage of 
phenylalanine in diet higher than 3% 
is not recommendable because of the 
so called amino acid toxicity of phe-
nylalanine and that the hyperpheny-
lalaninemic condition induced by ap-
plication of a high dosage of ethionine 
and phenylalanine induced severe loss 
of body weight. McDonald58 reported 
that reduced postnatal growth is an 
abiding feature of phenylketonuria in 
the mutant mouse model. 
As shown in Table (6), the level of blood 
phenylalanine was nearly the same 
among all groups of mice after induc-
table 6: Mean values of blood phenylalanine among all groups of mutagenesis mice model 
before start of treatment (Day 0) and during the feeding period (7, 14, 21, 28 days) compared 
with non mutagenesis mice in all groups (Control).
group of mice
Mean values of blood phenylalanine
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After 21 days of feeding, all the mice 
groups showed normal levels of phe-
nylalanine except for the group fed on 
basal diet which increased by 11.99% 
(5.545mg/dl). The decrease in phenyla-
lanine level in the group fed on barium 
sulphate-treated formula was 48.57% 
compared to only 42.94% decrease in 
the group fed on the  activated carbon-
treated formula. 
By the end of day 28, the mean values 
of phenylalanine were normalized in 
all the formulae-fed groups; being low-
est in the mice fed on bariun sulphate-
treated formula (1.292 mg/dl; 74.01% 
decrease) and their control group (0.376 
mg/dl; 71.96% decrease).
As shown in Table (7), the group of mu-
tagenesis mice fed on the formula treat-
tion of mutagenesis and before the start 
of feeding period (Day 0). There was no 
significant statistical difference between 
any of the 3 mice groups (P>0.05) with 
the blood phenylalanine values ranged 
between 4.951 and 4.986 mg/dl.
The levels of phenylalanine remained 
high in all mice groups at day 7 of feed-
ing compared to the control groups. At 
day 14 of feeding, the mean level of phe-
nylalanine increased by about 7.99% in 
the group of mice fed on basal diet but 
for the other 2 groups of feeding, there 
was 27.59% decrease in the mice fed on 
the formula treated by barium sulphate. 
The decrease was less in the group fed 
on the formula adsorbed on activated 
carbon (22.94% decrease). However, 
there was no significant statistical dif-
ference (P>0.05).
table 7: Follow-up table for the mean of weights, percentage of weight changes and 
percentage of surviving mutagenesis mice during the feeding period among all feeding 
groups
group of mice Feeding period (Day)
Mean weight 
(gm)







































































Percentage of mice remaining alive was 
highest in the group fed on the formula 
treated by barium sulphate (80%) com-
pared to only (20%) in the group fed 
on basal diet. About 20% of the exper-
imental mice were lost in each of the 
feeding formula groups during the 1st 
week of treatment period but the group 
fed on activated carbon lost addition-
ally about 40% by the 4th week of treat-
ment period.
On the other hand, the feeding on basal 
diet increased the blood level of pheny-
lalanine with increasing the mortality 
rate of mice.
This is in agreement with the findings 
of  Josef and Dyer35 who had placed 
phenylketonuric mice model on a low-
phenylalanine diet for 4 weeks so as to 
drop blood  phenylalanine levels from 
an eight–fold to normal control levels.
On the other hand, Yannicelli and Me-
deiros52 studied 54 male weanling PKU 
and control mice and assigned them to 
either elemental phenylalanine-restrict-
ed  diet  (Treated)  or phenylalanine-un-
restricted diet (Untreated) with low or 
normal protein levels for 56 days. The 
results were analyzed at baseline, at day 
28 and on day 56.
Delvalle and Greengard61 found that 
maximum increase in plasma phenyla-
lanine  on  day  15  of mutagenesis  was 
accompanied  by about 2% inhibition of 
brain and body growth. 
To conclude, the technique of  enzy-
matic hydrolysis could be the   most 
useful alternative for preparation of 
low phenylalanine formulae, not only 
because of the economic advantage, 
but also because of the minimal loss 
of nutritional value of milk compared 
to the general amino acids damage that 
may result from other methods e.g. al-
kali and acid treatment. These formulae 
may be helpful for dietary management 
of PKU  patients  as  well  as  moth-
ers with hyperphenylalaninemia. The 
BALB/c mice have been proved to be 
a suitable animal model to study phe-
nylketonuria disease. The use of 3% 
phenylalanine and 0.3% ethionine for 
21 days was proved to be effective for 
induction of hyperphenylalaninemia in 
mice model. 
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